LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

A Novel Non-Amplification Assay Detects Leishmania

By LabMedica International staff writers
Posted on 10 Mar 2014
Image: the Infinite M200 spectrophotometer (Photo courtesy of Tecan).
Image: the Infinite M200 spectrophotometer (Photo courtesy of Tecan).
The need for accurate diagnostic investigation of cases of leishmaniasis has made the use of molecular biology techniques broadly applicable for identifying the protozoan parasite.

The reliable application of these methods requires highly specialized personnel, dedicated equipment and space and because of these drawbacks of the molecular diagnostic approach, has targeted several alternatives and the most recent of which is the incorporation of nanoparticles for the detection of specific bio-molecules.

Laboratory scientists at the University of Athens (Greece) used for the assessment of the method’s specificity 15 cultured isolates of various Leishmania species from human and animal origin. There were 40 negative controls selected among pathogens genetically related to Leishmania spp., commonly found in clinical samples, both human and canine, as well as some bacterial species.

DNA isolation was performed on all samples by the Nucleospin Tissue kit (Macherey Nagel; Düren, Germany). Gold nanoparticles (AuNPs, Nanopartz; Salt Lake City, UT, USA) were conjugated with four oligonucleotide probes, targeting kinetoplastid minicircle DNA of Leishmania spp. The results were recorded by visual observation of the test tubes or by spectrophotometry (Infinite M200, Tecan; Männedorf Switzerland). In the absence of complimentary DNA, AuNPs-probes precipitate under acid environment causing a change of color from red to purple, which can be detected by visual observation. In the presence of target DNA the color of the solution remains red.

The assay produced consistently positive results detectable by simple visual observation of the test tubes with no less than 115 ng of leishmanial DNA in a sample volume of 10 μL and therefore the method's minimum detection limit was defined as 11.5 ng of target DNA per μL of sample. Repeatability and reproducibility were 100% and relative sensitivity and specificity referenced to a classical polymerase chain reaction (PCR) method were calculated to 92% and 100% regarding collectively control and clinical samples.

The authors concluded that the method provides an easy, fast, and inexpensive way for Leishmania DNA detection using AuNPs conjugated to four single strand oligonucleotide-probes. This approach can be considered an appealing diagnostic solution for resource-poor settings, especially for screening purposes in enzootic areas, where detection of very small amounts of the targeted analyte is not a top priority. The study was published in the January 2014 issue of the Journal of Microbiological Methods.

Related Links:

University of Athens
Macherey Nagel
Tecan


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Gold Member
Hematology Analyzer
Medonic M32B

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more